All News #Library
Biotech
Nature Communications Reveals Alpibectir`s Unique Action
13 Apr 2026 //
GLOBENEWSWIRE
BioVersys Strengthens Ansamycin Platform via Hackensack Deal
31 Mar 2026 //
GLOBENEWSWIRE
FDA Clears BioVersys BV100 for Phase 3 HABP/VABP Trials
16 Mar 2026 //
GLOBENEWSWIRE
BioVersys Doses First Patient in Phase 2b AlpE Pulmonary TB Trial
13 Mar 2026 //
GLOBENEWSWIRE
BioVersys Reports 2025 Results, Provides Update and Hosts Call
05 Mar 2026 //
GLOBENEWSWIRE
BioVersys Announces Publication of BV100 Ph1 Data in Journal
04 Mar 2026 //
GLOBENEWSWIRE
Bioversys Initiates BV100 Phase 3 Trial, Issues Business Update
11 Dec 2025 //
GLOBENEWSWIRE
BioVersys Reports Corporate Highlights and Key Financials 2024
26 Mar 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support